UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063580
Receipt number R000072758
Scientific Title Effects of Thermotherapy and Stretching on Soft Tissue Extensibility
Date of disclosure of the study information 2026/11/11
Last modified on 2026/11/10 13:36:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effects of Heat Therapy and Stretching on Body Flexibility

Acronym

Effects of Heat Therapy and Stretching on Flexibility

Scientific Title

Effects of Thermotherapy and Stretching on Soft Tissue Extensibility

Scientific Title:Acronym

Thermotherapy and Stretching for Soft Tissue Extensibility

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Limited range of motion (ROM) is a common functional impairment that significantly hinders daily living. Its causes are extremely diverse, ranging from soft tissues surrounding the joint, such as the skin, skeletal muscles, and joint capsule, to joint components such as bone and cartilage. ROM restrictions rank among the top three conditions treated in physical therapy and are a critical functional impairment that must be addressed in the field of rehabilitation (Japan Association of Physical Therapists, 1990-2010).
The causes of ROM restrictions that can be expected to improve through conservative treatments such as physical therapy are related to the soft tissues surrounding the joints (Okita, 2014). Treatment strategies include physical therapy centered on heat therapy and exercise therapy, such as stretching. Previous studies have shown that heat therapy and stretching are effective in improving the extensibility of soft tissues (Harvey et al., 2017; Nakano et al., 2012). However, for both treatment methods, there has not yet been sufficient verification of factors such as the optimal duration and frequency required to maximize their effectiveness.
Therefore, the purpose of this study is to verify the optimal methods of heat therapy and stretching to improve soft tissue extensibility.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

range of motion (Before and After Intervention)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Sham Treatment

Interventions/Control_2

Thermal therapy
Duration: 1-30 minutes
Frequency: 1-5 times per week for 1-3 weeks

Interventions/Control_3

Stretching
Duration: 10-60 seconds
Frequency: 1-5 times per set, 1-5 times per week for 1-3 weeks

Interventions/Control_4

Thermal therapy + Stretching

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants must be able-bodied individuals aged 18 or older who, after receiving an oral and written explanation of the purpose and methods of the study, as well as the risks and lack of compensation associated with participation, have provided written consent indicating their voluntary participation.

Key exclusion criteria

Individuals who report severe pain that interferes with daily life, those with typical physical disabilities caused by conditions such as cerebrovascular disease or rheumatoid arthritis, and those with a history of fractures or other conditions in the upper extremities resulting in joint fusion are excluded.

Target sample size

72


Research contact person

Name of lead principal investigator

1st name Kenichiro
Middle name
Last name Miyahara

Organization

Hokuriku University

Division name

Faculty of health and medical sciences

Zip code

9201180

Address

1-1 Taiyogaoka, Kanazawa

TEL

076291161

Email

k-miyahara@hokuriku-u.ac.jp


Public contact

Name of contact person

1st name Kenichiro
Middle name
Last name Miyahara

Organization

Hokuriku University

Division name

Faculty of health and medical sciences

Zip code

9201180

Address

1-1 Taiyogaoka, Kanazawa

TEL

0762291161

Homepage URL


Email

k-miyahara@hokuriku-u.ac.jp


Sponsor or person

Institute

Hokuriku University

Institute

Department

Personal name

Kenichiro Miyahara


Funding Source

Organization

Hokuriku University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokuriku University

Address

1-1 Taiyogaoka, Kanazawa

Tel

0762291161

Email

k-miyahara@hokuriku-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 12 Month 25 Day

Date of IRB

2025 Year 12 Month 25 Day

Anticipated trial start date

2025 Year 12 Month 25 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 10 Day

Last modified on

2026 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072758